Stay updated with breaking news from View Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEATTLE, May 04, 2021, (PHARMIWEB) —Pain relief is provided by synthetic opioids. Synthetic opioids have a similar effect on the body as other opioids. Opioid receptor agonists function mainly on the brain and spinal cord in these drugs. Synthetic opioids have a greater effectiveness over most pain relievers, such a...
SEATTLE, April 29, 2021, (PHARMIWEB) — OverviewOsteoporosis is defined by the micro-architectural degradation of bone tissue, which results in low bone mass and bone fragility, especially in older people. Women are more susceptible to the condition over men, particularly after menopause, when bone loss is increased...
Search jobs 29-Apr-2021 SEATTLE, April 29, 2021, (PHARMIWEB) — Overview: Glaucoma is a category of diseases marked by optic nerve injury, visual field loss, and secondary retinal ganglion cell damage, both of which can result in death. Glaucoma is the world’s second leading cause of blindness and the leading cause of permanent blindness globally, according to the International Agency for the Prevention of Blindness. Primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG) are the two most common forms of glaucoma. The chance of developing glaucoma ...
Search jobs 12-Apr-2021 [2021] Saline Laxatives Market is Expected to Surge with 5.0% CAGR With US$ 613.3 Million by 2027 – Coherent Market Insights SEATTLE, April 12, 2021, (PHARMIWEB) — The global saline laxatives market, by Age Group (Pediatric and Adult), By Route of Administration (Oral and Rectal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), accounted for US$ 396.3 million in 2019, and is projected to w...
CAGR of 10.1% during the forecast period (2018-2026). Market Analysis: Rampant development of liquid ursodeoxycholic acid has offered ample growth opportunities to the companies operating in the global ursodeoxycholic acid market in the recent past. With the introduction of liquid formulations of ursodeoxycholic acid, healthcare professionals are now able to prescribe an alternate dosing method to patients who have difficulty in swallowing tablets or capsules. Extensive R&D of ursodeoxycholic acid, along with a high prevalence of diseases like gallstone and liver cirrhosis, has majorly boos...